Salient Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-61,260
| Closed | -$1.95M | – | 151 |
|
|
2017
Q2 | $1.95M | Sell |
61,260
-18,640
| -23% | -$594K | 0.04% | 102 |
|
|
2017
Q1 | $2.59M | Sell |
79,900
-10,086
| -11% | -$327K | 0.05% | 96 |
|
|
2016
Q4 | $2.77M | Sell |
89,986
-703
| -0.8% | -$21.7K | 0.05% | 88 |
|
|
2016
Q3 | $2.91M | Sell |
90,689
-18,849
| -17% | -$606K | 0.06% | 85 |
|
|
2016
Q2 | $3.66M | Hold |
109,538
| – | – | 0.08% | 77 |
|
|
2016
Q1 | $3.08M | Buy |
109,538
+23,621
| +27% | +$664K | 0.09% | 81 |
|
|
2015
Q4 | $2.63M | Buy |
85,917
+7,236
| +9% | +$222K | 0.07% | 87 |
|
|
2015
Q3 | $2.35M | Buy |
78,681
+21,350
| +37% | +$636K | 0.06% | 92 |
|
|
2015
Q2 | $1.82M | Buy |
57,331
+3,172
| +6% | +$101K | 0.03% | 115 |
|
|
2015
Q1 | $1.79M | Buy |
54,159
+6,282
| +13% | +$207K | 0.03% | 107 |
|
|
2014
Q4 | $1.42M | Buy |
47,877
+4,268
| +10% | +$126K | 0.03% | 133 |
|
|
2014
Q3 | $1.22M | Sell |
43,609
-5,649
| -11% | -$158K | 0.02% | 143 |
|
|
2014
Q2 | $1.39M | Sell |
49,258
-14,793
| -23% | -$417K | 0.03% | 123 |
|
|
2014
Q1 | $1.95M | Sell |
64,051
-4,646
| -7% | -$142K | 0.05% | 99 |
|
|
2013
Q4 | $2M | Buy |
68,697
+833
| +1% | +$24.2K | 0.06% | 90 |
|
|
2013
Q3 | $1.85M | Buy |
67,864
+2,705
| +4% | +$73.7K | 0.08% | 81 |
|
|
2013
Q2 | $1.73M | Buy |
+65,159
| New | +$1.73M | 0.08% | 82 |
|